Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methodological Design for Evaluating the Immune Capacity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 Human Infection: Intelligent Medicine Integration.

NCT05054075 is registered in ClinicalTrials.gov with Universidade do Porto as lead sponsor.

NCT NCT05054075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05054075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methodological Design for Evaluating the Immune Capacity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 Human Infection: Intelligent Medicine Integration.
Lead sponsor
Universidade do Porto
Phase
Phase 2
Overall status
Unknown status
Start date
October 1, 2021
Completion date
November 30, 2022
Enrollment
45 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infections, coronavirus sars-associated, covid-19, sars (severe acute respiratory syndrome)